Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $65523.0.

  • Neuroone Medical Technologies' Depreciation & Amortization (CF) rose 60.8% to $65523.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $262075.0, marking a year-over-year increase of 348.02%. This contributed to the annual value of $261679.0 for FY2025, which is 603.26% up from last year.
  • As of Q4 2025, Neuroone Medical Technologies' Depreciation & Amortization (CF) stood at $65523.0, which was up 60.8% from $64324.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Depreciation & Amortization (CF) high stood at $66594.0 for Q2 2025, and its period low was $19294.0 during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $47694.6, with a median of $57807.5 in 2023.
  • Per our database at Business Quant, Neuroone Medical Technologies' Depreciation & Amortization (CF) surged by 8702.95% in 2023 and then soared by 30.72% in 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Depreciation & Amortization (CF) (Quarter) stood at $25161.0 in 2021, then skyrocketed by 42.64% to $35889.0 in 2022, then surged by 63.44% to $58657.0 in 2023, then grew by 11.03% to $65127.0 in 2024, then increased by 0.61% to $65523.0 in 2025.
  • Its last three reported values are $65523.0 in Q4 2025, $64324.0 for Q3 2025, and $66594.0 during Q2 2025.